文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism.

作者信息

Gunter Jennifer H, Kruithof-de Julio Marianna, Zoni Eugenio

机构信息

School of Biomedical Sciences, Faculty of Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, QLD, Australia.

Australian Prostate Cancer Research Centre-Queensland (APCRC-Q), Translational Research Institute, Queensland University of Technology, Woolloongabba, QLD, Australia.

出版信息

Front Oncol. 2022 Mar 3;12:862811. doi: 10.3389/fonc.2022.862811. eCollection 2022.

DOI:10.3389/fonc.2022.862811
PMID:35311129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928736/
Abstract
摘要

相似文献

[1]
Editorial: Personalized Medicine for Urological Cancers: Targeting Cancer Metabolism.

Front Oncol. 2022-3-3

[2]
Current Trends in the Incidence and Survival Rate of Urological Cancers in Korea.

Cancer Res Treat. 2017-7

[3]
Editorial: Precision Medicine and Translational Research in Urological Oncology.

Front Oncol. 2022-7-5

[4]
Incidence of kidney, bladder, and prostate cancers in Korea: An update.

Korean J Urol. 2015-6

[5]
Hospital volume and postoperative survival for three urological cancers: Prostate, kidney, and bladder.

Int J Urol. 2021-8

[6]
Current status of organoid culture in urological malignancy.

Int J Urol. 2022-2

[7]
The effect of primary urological cancers on survival in men with secondary prostate cancer.

Prostate. 2021-11

[8]
Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: a descriptive study.

BMC Cancer. 2015-10-21

[9]
Personalized peptide vaccines and their relation to other therapies in urological cancer.

Nat Rev Urol. 2017-5-31

[10]
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.

Med Oncol. 2019-9-13

引用本文的文献

[1]
Immunosuppressive Signaling Pathways as Targeted Cancer Therapies.

Biomedicines. 2022-3-16

本文引用的文献

[1]
A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancer.

Lab Invest. 2021-9

[2]
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications.

Int J Mol Sci. 2020-8-7

[3]
Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases.

Oncogene. 2020-3-5

[4]
Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.

BMC Cancer. 2019-12-16

[5]
Involvement of Gastrin-Releasing Peptide Receptor in the Regulation of Adipocyte Differentiation in 3T3-L1 Cells.

Int J Mol Sci. 2018-12-10

[6]
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors.

J Hematol Oncol. 2016-10-4

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索